invoke
发表于 2025-3-21 18:52:21
书目名称Guide to Clinical Management of Idiopathic Pulmonary Fibrosis影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0390797<br><br> <br><br>书目名称Guide to Clinical Management of Idiopathic Pulmonary Fibrosis影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0390797<br><br> <br><br>书目名称Guide to Clinical Management of Idiopathic Pulmonary Fibrosis网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0390797<br><br> <br><br>书目名称Guide to Clinical Management of Idiopathic Pulmonary Fibrosis网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0390797<br><br> <br><br>书目名称Guide to Clinical Management of Idiopathic Pulmonary Fibrosis被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0390797<br><br> <br><br>书目名称Guide to Clinical Management of Idiopathic Pulmonary Fibrosis被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0390797<br><br> <br><br>书目名称Guide to Clinical Management of Idiopathic Pulmonary Fibrosis年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0390797<br><br> <br><br>书目名称Guide to Clinical Management of Idiopathic Pulmonary Fibrosis年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0390797<br><br> <br><br>书目名称Guide to Clinical Management of Idiopathic Pulmonary Fibrosis读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0390797<br><br> <br><br>书目名称Guide to Clinical Management of Idiopathic Pulmonary Fibrosis读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0390797<br><br> <br><br>
Foam-Cells
发表于 2025-3-21 23:54:36
Diseases that Mimic Idiopathic Pulmonary Fibrosis,There are number of conditions that may commonly be confused and difficult to differentiate from idiopathic pulmonary fibrosis (IPF). This chapter discusses these conditions in more detail.
Arthropathy
发表于 2025-3-22 02:45:27
http://reply.papertrans.cn/40/3908/390797/390797_3.png
Badger
发表于 2025-3-22 08:14:23
http://reply.papertrans.cn/40/3908/390797/390797_4.png
无意
发表于 2025-3-22 09:06:03
https://doi.org/10.1007/978-3-642-28708-4. There are two agents that have been shown to slow the rate of deterioration in lung function in IPF. These two drugs, pirfenidone and nintedanib, have been variably approved in countries around the world.
Spina-Bifida
发表于 2025-3-22 14:31:05
http://reply.papertrans.cn/40/3908/390797/390797_6.png
Spina-Bifida
发表于 2025-3-22 21:08:21
http://reply.papertrans.cn/40/3908/390797/390797_7.png
极少
发表于 2025-3-23 00:56:57
Treatment of Idiopathic Pulmonary Fibrosis,. There are two agents that have been shown to slow the rate of deterioration in lung function in IPF. These two drugs, pirfenidone and nintedanib, have been variably approved in countries around the world.
无聊的人
发表于 2025-3-23 02:09:56
http://reply.papertrans.cn/40/3908/390797/390797_9.png
鉴赏家
发表于 2025-3-23 08:08:09
Clinical Presentation and Diagnosis,are more likely to notice the onset of their symptoms sooner compared to those patients who are more sedentary. Given the non-specific symptoms of idiopathic pulmonary fibrosis (IPF), patients are frequently misdiagnosed initially. Non-specific symptoms include: